Here in this study, we present the initial clinical results (ChiCTR2000032124) of one patient with Non-Hodgkin lymphoma (NHL) and two patients with multiple myeloma (MM) treated with CART-aIL6/IL1RA with GM-CSF/TCR KO. This evidence concerns the gene CSF2 and Miyoshi myopathy.